Prof. Dr. Christoph Bert

Department of Radiation Oncology

Research projects

  • Medical physics in radiation therapy with a focus on quality assurance for brachytherapy
  • Management of organ motion (4DCT, tracking)
  • Optimization of imaging for RT treatment planning.
  • Electromagnetic tracking for quality assurance in interstitial brachytherapy
  • Digital Twin for online validation of Medical device networks –
  • Optimization of MR imaging for radiotherapy
  • Risk management in radiation therapy –
  • Several topics w.r.t. Optimizing the therapy
  • Quality assurance

Current projects

  • Verbundprojekt: Intelligente Tumorverfolgung für die Strahlentherapie (INSIGHT) - Teilvorhaben: Echtzeitverfolgung von Tumorzielvolumina – Autosegmentierung und Validierung

    (Third Party Funds Group – Sub project)

    Overall project: Intelligente Tumorverfolgung für die Strahlentherapie (INSIGHT)
    Term: 1. June 2024 - 31. May 2027
    Funding source: BMBF / Verbundprojekt
  • Entwicklung eines Datenanalyse- und Kommunikations-Clusters zur Unterstützung klinischer Abläufe mit dem Ziel der Steigerung der Behandlungsqualität

    (Third Party Funds Single)

    Term: 1. April 2024 - 31. March 2027
    Funding source: Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie (StMWi) (seit 2018)
  • Clinical traslatio of FLASHKNiFE, a promising device for ultrahigh dose-rate radiation therapy (FLASHKNiFE)

    (Third Party Funds Single)

    Term: 1. January 2024 - 31. December 2024
    Funding source: Europäische Union (EU)
  • J102: The role of cDC1s in abscopal effects of a multimodal radioimmunotherapy including whole tumor cell vaccines

    (FAU Funds)

    Term: 1. December 2022 - 31. May 2025
    Abscopal effects are rare events of local radiotherapy (RT) inducing systemic anti-tumor immune responses leading to the reduction of tumor masses outside of the irradiation field. We hypothesize that the addition of adjuvants to high hydrostatic pressure generated whole tumor cell vaccines in combination with RT and immune checkpoint inhibition induce abscopal effects in an orthotopic breast cancer model. Further, we hypothesize that cDC1s play a central role in this immune response.

Recent publications






Related Research Fields